Log In Get Started

News Hub

Real-time financial, economic, and global news with market-focused context and analysis.

Coverage spans equities, macroeconomic data, commodities, currencies, technology, politics, and global events—paired with analysis that highlights why each development matters for traders and investors. From breaking headlines to hourly market snapshots and in-depth articles, the News Hub is designed to help you stay informed, oriented, and ahead of market-moving events.

  • Cavco Industries will report fiscal 2027 Q1 results after market close on July 30, followed by a management webcast on July 31.
  • Cavco is a U.S. factory-built homes and modular commercial structures manufacturer with finance and insurance subsidiaries.
  • Cavco results will act as a near-term signal for manufactured-housing demand and related finance performance.
  • FANUY (FANUC ADR) is promoted as a tactical buy-the-dip trade supported by AI and robotics partnership momentum.
  • Technically, FANUY has pulled below short- and mid-term moving averages, creating a defined-risk long setup with 180-day catalysts.

Latest Articles

Edible Garden Accelerates Path to Profitability Through Major Logistics Transformation, Reducing Operating Costs, Lowering Emissions and Enhancing Supply Chain Efficiency
Jun 1, 2026
Hana Yamamoto
Press Releases

Edible Garden Accelerates Path to Profitability Through Major Logistics Transformation, Reducing Operating Costs, Lowering Emissions and Enhancing Supply Chain Efficiency

Edible Garden AG Incorporated has completed a major logistics overhaul in the Metro New York area, shifting from a Direct Store Delivery model to a direct-to-distribution-center and regional hub model. This change is expected to significantly reduce transportation costs and carbon emissions, improving operational efficiency and supporting the compa…

EDBL
Morgan Stanley Sees Broader Cyclical Recovery as Earnings Revisions Improve
Jun 1, 2026
Maya Rios
Stock Markets

Morgan Stanley Sees Broader Cyclical Recovery as Earnings Revisions Improve

Morgan Stanley's equity team is growing more constructive on economically sensitive sectors, citing improving earnings revisions across Consumer Discretionary, Transportation and Financials. The bank points to lighter positioning, easing yields and pockets of strengthening fundamentals - notably in trucking and regional banking - as evidence the cy…

Piedmont REIT Signs 240,000 SF of Leases Second Quarter-to-Date Bringing YTD Leasing to approximately 670,000 SF
Jun 1, 2026
Priya Menon
Press Releases

Piedmont REIT Signs 240,000 SF of Leases Second Quarter-to-Date Bringing YTD Leasing to approximately 670,000 SF

Piedmont Realty Trust announced that it has signed approximately 240,000 square feet of leases in the second quarter so far, with more than 60% representing new tenant leasing and 90% of new leases for previously vacant spaces. This brings the year-to-date leasing volume to approximately 670,000 square feet. The company highlights sustained high de…

PDM
Private credit supplied $560 billion in U.S. loans since 2023, MFA finds
Jun 1, 2026
Avery Klein
Stock Markets

Private credit supplied $560 billion in U.S. loans since 2023, MFA finds

Private credit funds extended nearly $560 billion in new loans to U.S. companies over the past three years, supporting millions of jobs and generating substantial economic activity, according to a Managed Funds Association report. The industry’s growth has coincided with reduced risk-taking by traditional lenders and larger institutional allocation…

IREN Closes $3.65bn Investment-Grade GPU Financing
Jun 1, 2026
Derek Hwang
Press Releases

IREN Closes $3.65bn Investment-Grade GPU Financing

IREN Limited has successfully closed a $3.65 billion investment-grade GPU financing facility, the largest publicly rated GPU financing to date, to support its AI Cloud contract with Microsoft. The facility includes a $2.10 billion U.S. private placement and a $1.55 billion delayed draw term loan, funding 96% of the $5.81 billion GPU capital expendi…

IREN
SAIC Announces First Quarter of Fiscal Year 2027 Results
Jun 1, 2026
Leila Farooq
Press Releases

SAIC Announces First Quarter of Fiscal Year 2027 Results

Science Applications International Corporation (SAIC) announced its Q1 FY2027 results with revenues of $1.91 billion, a 2% increase including acquisitions, and modest organic growth of 0.5%. The company reported adjusted EBITDA of $222 million, a 41% increase year-over-year, and adjusted diluted EPS of $3.23, up 68%. Cash flow from operations impro…

SAIC
Japan Says Chinese Carrier Liaoning Conducted Drills East of the Philippines
Jun 1, 2026
Nina Shah
World

Japan Says Chinese Carrier Liaoning Conducted Drills East of the Philippines

Japan's defence ministry reported that the Chinese aircraft carrier Liaoning and its accompanying vessels carried out carrier flight drills in the Pacific Ocean east of the Philippine island of Luzon between May 26 and May 28. The bulletin said the carrier group conducted about 170 take-offs and landings and sailed as close as 590 km southeast of M…

Invivyd Announces Completion of Enrollment in Upsized DECLARATION Clinical Trial, a Phase 3 Pivotal Study of VYD2311, an Investigational Antibody to Prevent COVID
Jun 1, 2026
Ajmal Hussain
Press Releases

Invivyd Announces Completion of Enrollment in Upsized DECLARATION Clinical Trial, a Phase 3 Pivotal Study of VYD2311, an Investigational Antibody to Prevent COVID

Invivyd, Inc., a U.S.-based biopharmaceutical company, announced the completion of enrollment in its Phase 3 DECLARATION clinical trial testing VYD2311, an investigational monoclonal antibody administered intramuscularly for the prevention of symptomatic COVID-19. The trial was upsized by approximately 500 subjects to enhance statistical power due …

IVVD
Jade Biosciences Announces Positive Interim Phase 1 Results for JADE101 Demonstrating Potential Best-in-Class Profile and Every-12-Week Dosing in IgA Nephropathy
Jun 1, 2026
Jordan Park
Press Releases

Jade Biosciences Announces Positive Interim Phase 1 Results for JADE101 Demonstrating Potential Best-in-Class Profile and Every-12-Week Dosing in IgA Nephropathy

Jade Biosciences announced positive interim Phase 1 trial results of JADE101, a novel anti-APRIL monoclonal antibody for immunoglobulin A nephropathy (IgAN). Results demonstrated approximately 70% sustained IgA reduction at 12 weeks after a single dose, with potential for every 12-week subcutaneous maintenance dosing. JADE101 showed faster, deeper,…

JBIO
Monopar Presents Phase 2 ALXN1840 Data Demonstrating Liver Disease Stabilization and Neurologic Improvement in Treatment-Experienced Wilson Disease Patients at EASL 2026
Jun 1, 2026
Jordan Park
Press Releases

Monopar Presents Phase 2 ALXN1840 Data Demonstrating Liver Disease Stabilization and Neurologic Improvement in Treatment-Experienced Wilson Disease Patients at EASL 2026

Monopar Therapeutics presented Phase 2 clinical trial results of ALXN1840 at EASL 2026, demonstrating stabilization of liver disease and significant neurological improvements in treatment-experienced Wilson disease patients. The therapy was well tolerated and improved patients' quality of life, highlighting its potential as a novel treatment option…

MNPR
Axsome Therapeutics Partners with the Headache Alliance to Highlight the Impact of Migraine During Migraine and Headache Awareness Month
Jun 1, 2026
Maya Rios
Press Releases

Axsome Therapeutics Partners with the Headache Alliance to Highlight the Impact of Migraine During Migraine and Headache Awareness Month

Axsome Therapeutics is supporting the Headache Alliance’s first annual Headache in the City campaign and raising awareness during Migraine and Headache Awareness Month. The company highlights the significant impact of migraine and shares educational resources, reinforcing its commitment to the migraine community as part of its broader mission to tr…

AXSM
Kinross releases 2025 Sustainability Report
Jun 1, 2026
Nina Shah
Press Releases

Kinross releases 2025 Sustainability Report

Kinross Gold Corporation released its comprehensive 2025 Sustainability Report, showcasing progress in health and safety, community investment, environmental management, and energy efficiency. The report underscores the company's leadership in sustainability ratings within the mining sector, increased female workforce representation, substantial ec…

KGC
Ollie’s Bargain Outlet Holdings, Inc. Appoints Jared Shure as Senior Vice President, General Counsel and Corporate Secretary
Jun 1, 2026
Jordan Park
Press Releases

Ollie’s Bargain Outlet Holdings, Inc. Appoints Jared Shure as Senior Vice President, General Counsel and Corporate Secretary

Ollie’s Bargain Outlet has named Jared Shure as Senior Vice President, General Counsel, and Corporate Secretary. Shure brings nearly 20 years of legal and business experience from previous roles at The Children’s Place, Kate Spade, and Tapestry. He will oversee legal, compliance, and corporate governance functions, aiming to support the company’s s…

OLLI
Fractyl Health Appoints Mike Zumdahl as Senior Vice President, Market Access and Commercial Strategy
Jun 1, 2026
Ajmal Hussain
Press Releases

Fractyl Health Appoints Mike Zumdahl as Senior Vice President, Market Access and Commercial Strategy

Fractyl Health, a clinical-stage metabolic therapeutics company, has appointed Mike Zumdahl as Senior Vice President of Market Access and Commercial Strategy. Zumdahl brings extensive experience in health economics and reimbursement, having previously led market access at Inari Medical and contributed to launching the GLP-1 category at Novo Nordisk…

GUTS
Weatherford Announces Definitive Agreement to Acquire NCS Multistage, Expanding Completions Portfolio and Unconventional Resource Exposure
Jun 1, 2026
Leila Farooq
Press Releases

Weatherford Announces Definitive Agreement to Acquire NCS Multistage, Expanding Completions Portfolio and Unconventional Resource Exposure

Weatherford International plc (NASDAQ: WFRD) has entered into a definitive agreement to acquire NCS Multistage Holdings, Inc. (NASDAQ: NCSM). The acquisition aims to expand Weatherford's completions portfolio and deepen its capabilities in the unconventional oil and gas segment. The deal is expected to be accretive to free cash flow per share and d…

WFRD
Marex Group plc acquires Levmet
Jun 1, 2026
Avery Klein
Press Releases

Marex Group plc acquires Levmet

Marex Group plc (NASDAQ: MRX), a global financial services platform, has acquired Levmet, a Monaco-based liquidity provider in physical and derivatives markets for metals and energy. The acquisition strengthens Marex’s physical market making operations and expands their capabilities in European power and gas trading, aligning with their strategy to…

MRX
Actuate Therapeutics Announces ASCO Poster Presentations Demonstrating Compelling Clinical and Biomarker Data for Elraglusib in First-Line Metastatic Pancreatic Cancer
Jun 1, 2026
Jordan Park
Press Releases

Actuate Therapeutics Announces ASCO Poster Presentations Demonstrating Compelling Clinical and Biomarker Data for Elraglusib in First-Line Metastatic Pancreatic Cancer

Actuate Therapeutics announced positive clinical and biomarker data from Phase 2 studies demonstrating that elraglusib, combined with standard chemotherapy regimens gemcitabine/Abraxane and FOLFIRINOX, significantly improves median overall survival in patients with metastatic pancreatic ductal adenocarcinoma, especially those with specific wild-typ…

ACTU
Waldencast Announces Sale of Obagi Medical to Bridgepoint
Jun 1, 2026
Jordan Park
Press Releases

Waldencast Announces Sale of Obagi Medical to Bridgepoint

Waldencast plc has entered into an agreement to sell its dermatological skincare brand Obagi Medical to Bridgepoint for up to $460 million. The deal will strengthen Waldencast's balance sheet and allow the company to concentrate on expanding its other beauty brand, Milk Makeup. The transaction is expected to close in Q3 2026, with Waldencast planni…

WALD